首页 > 最新文献

Canadian Journal of Respiratory Therapy最新文献

英文 中文
Survival analysis of COVID-19 versus non-COVID-19 patients requiring intensive care for acute respiratory distress syndrome: An observational retrospective study. 因急性呼吸窘迫综合征需要接受重症监护的 COVID-19 与非 COVID-19 患者的生存分析:一项观察性回顾研究。
0 CRITICAL CARE MEDICINE Pub Date : 2024-08-21 eCollection Date: 2024-01-01 DOI: 10.29390/001c.122402
Paulo Navas Boada, Kevin Chamorro, Santiago Ballaz

Background/aim: This study analyzed clinical factors impacting the survival of COVID-19 patients with acute respiratory distress síndrome, or ARDS (CARDS) to ICU compared to non-COVID-19 ARDS patients.

Methods: Clinical variables from 1,008 CARDS cases and 332 ARDS cases were computed using learning algorithms. The multivariable Cox proportional hazards regression models with the enter method evaluated risk factors and ICU mortality relationships. The survival analysis was completed with Kaplan-Meier and the log-rank tests.

Results: A Random Forest model revealed that mechanical ventilation-related factors, oxygenation, blood pH, superinfection, shock, and ICU length of stay have the greatest effects on ICU survival. According to a multivariate Cox model, reintubation and a high-flow nasal cannula were essential for survival in CARDS patients during the ICU stay. The length of stay in the ICU diminishes in patients older than 45 years, regardless of the source of ARDS.

Conclusion: This study gives recommendations for the respiratory care of ARDS in COVID-19 patients.

背景/目的:与非COVID-19型ARDS患者相比,本研究分析了影响COVID-19型急性呼吸窘迫综合征或ARDS(CARDS)患者入住ICU存活率的临床因素:使用学习算法计算了 1008 例 CARDS 和 332 例 ARDS 的临床变量。采用 enter 方法建立的多变量 Cox 比例危险回归模型评估了风险因素与 ICU 死亡率之间的关系。生存分析采用卡普兰-梅耶尔检验和对数秩检验完成:随机森林模型显示,机械通气相关因素、氧饱和度、血液pH值、超级感染、休克和ICU住院时间对ICU生存率的影响最大。根据多变量 Cox 模型,重新插管和高流量鼻插管对 CARDS 患者在重症监护室的存活率至关重要。无论 ARDS 的来源如何,45 岁以上的患者在重症监护室的住院时间都会缩短:本研究为COVID-19患者的ARDS呼吸护理提供了建议。
{"title":"Survival analysis of COVID-19 versus non-COVID-19 patients requiring intensive care for acute respiratory distress syndrome: An observational retrospective study.","authors":"Paulo Navas Boada, Kevin Chamorro, Santiago Ballaz","doi":"10.29390/001c.122402","DOIUrl":"https://doi.org/10.29390/001c.122402","url":null,"abstract":"<p><strong>Background/aim: </strong>This study analyzed clinical factors impacting the survival of COVID-19 patients with acute respiratory distress síndrome, or ARDS (CARDS) to ICU compared to non-COVID-19 ARDS patients.</p><p><strong>Methods: </strong>Clinical variables from 1,008 CARDS cases and 332 ARDS cases were computed using learning algorithms. The multivariable Cox proportional hazards regression models with the enter method evaluated risk factors and ICU mortality relationships. The survival analysis was completed with Kaplan-Meier and the log-rank tests.</p><p><strong>Results: </strong>A Random Forest model revealed that mechanical ventilation-related factors, oxygenation, blood pH, superinfection, shock, and ICU length of stay have the greatest effects on ICU survival. According to a multivariate Cox model, reintubation and a high-flow nasal cannula were essential for survival in CARDS patients during the ICU stay. The length of stay in the ICU diminishes in patients older than 45 years, regardless of the source of ARDS.</p><p><strong>Conclusion: </strong>This study gives recommendations for the respiratory care of ARDS in COVID-19 patients.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"112-121"},"PeriodicalIF":0.0,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11392457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of physical activity levels in people with chronic obstructive pulmonary disease and healthy subjects residing in hypobaric hypoxia environments. 慢性阻塞性肺病患者与居住在低压缺氧环境中的健康人体育活动水平的比较。
N/A CRITICAL CARE MEDICINE Pub Date : 2024-08-15 eCollection Date: 2024-01-01 DOI: 10.29390/001c.122163
Wilder A Villamil-Parra

Background: The reduced level of physical activity in individuals with chronic obstructive pulmonary disease (COPD) is associated with disease severity; however, mild COPD may or may not decrease individuals' physical fitness. Currently, it is unknown whether high-altitude hypoxia is a modifying factor of physical activity levels in COPD compared to healthy subjects.

Objective: To compare physical activity levels in individuals with COPD versus healthy subjects residing in high-altitude environments.

Methods: Individuals with COPD GOLD 1(A, B) and control subjects residing at high altitudes (>2500m) were studied. Physical activity level was measured for seven days using triaxial accelerometry. Measurement variables included METs/hour, energy expenditure in kcal/hour, total daily energy expenditure, and number of steps per day.

Results: Daily caloric expenditure associated with physical activity showed only a slight decrease (3.1%) in COPD patients compared to the control group; there was a significant 61.32% lower hourly calorie consumption rate in the COPD group. Additionally, COPD patients exhibited lower MET/hour (9.64% difference) and a substantial difference in the number of steps per day, with 139.41% fewer steps compared to the control group.

Conclusion: COPD patients in hypobaric hypoxia environments exhibit significantly lower levels of physical activity compared to healthy individuals. Altitude hypoxia contributes to low levels of physical activity in both COPD patients and healthy subjects.

背景:慢性阻塞性肺病(COPD)患者体力活动量的减少与疾病的严重程度有关;然而,轻度慢性阻塞性肺病可能会也可能不会降低患者的体能。与健康受试者相比,目前尚不清楚高海拔缺氧是否是慢性阻塞性肺病患者体力活动水平的一个调节因素:比较慢性阻塞性肺病患者与居住在高海拔环境中的健康人的体力活动水平:研究对象为居住在高海拔地区(海拔超过 2500 米)的 COPD GOLD 1(A、B)患者和对照组受试者。使用三轴加速度计测量了七天的体力活动水平。测量变量包括 METs/小时、能量消耗(千卡/小时)、每日总能量消耗和每日步数:与对照组相比,慢性阻塞性肺病患者与体力活动相关的每日热量消耗仅略有下降(3.1%);慢性阻塞性肺病组的每小时热量消耗率显著降低了 61.32%。此外,与对照组相比,慢性阻塞性肺病患者的 MET/小时较低(差异为 9.64%),每天的步数也有很大差异,减少了 139.41%:结论:与健康人相比,低海拔缺氧环境中的慢性阻塞性肺病患者的体力活动水平明显较低。高原缺氧导致慢性阻塞性肺病患者和健康人的体力活动水平都很低。
{"title":"Comparison of physical activity levels in people with chronic obstructive pulmonary disease and healthy subjects residing in hypobaric hypoxia environments.","authors":"Wilder A Villamil-Parra","doi":"10.29390/001c.122163","DOIUrl":"10.29390/001c.122163","url":null,"abstract":"<p><strong>Background: </strong>The reduced level of physical activity in individuals with chronic obstructive pulmonary disease (COPD) is associated with disease severity; however, mild COPD may or may not decrease individuals' physical fitness. Currently, it is unknown whether high-altitude hypoxia is a modifying factor of physical activity levels in COPD compared to healthy subjects.</p><p><strong>Objective: </strong>To compare physical activity levels in individuals with COPD versus healthy subjects residing in high-altitude environments.</p><p><strong>Methods: </strong>Individuals with COPD GOLD 1(A, B) and control subjects residing at high altitudes (>2500m) were studied. Physical activity level was measured for seven days using triaxial accelerometry. Measurement variables included METs/hour, energy expenditure in kcal/hour, total daily energy expenditure, and number of steps per day.</p><p><strong>Results: </strong>Daily caloric expenditure associated with physical activity showed only a slight decrease (3.1%) in COPD patients compared to the control group; there was a significant 61.32% lower hourly calorie consumption rate in the COPD group. Additionally, COPD patients exhibited lower MET/hour (9.64% difference) and a substantial difference in the number of steps per day, with 139.41% fewer steps compared to the control group.</p><p><strong>Conclusion: </strong>COPD patients in hypobaric hypoxia environments exhibit significantly lower levels of physical activity compared to healthy individuals. Altitude hypoxia contributes to low levels of physical activity in both COPD patients and healthy subjects.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"103-111"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11330300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volatile gas scavenging in the paediatric intensive care unit: Occupational health and safety assessment. 儿科重症监护室的挥发性气体清除:职业健康与安全评估。
Q2 Health Professions Pub Date : 2024-06-18 eCollection Date: 2024-01-01 DOI: 10.29390/001c.118513
Katherine Reise, Jason Macartney, Richard La, Angela Jerath, Marat Slessarev, Brian H Cuthbertson, Saptharishi Lalgudi Ganesan, Nicole K McKinnon

Introduction: The use of volatile anesthetic agents in the paediatric intensive care unit (PICU) is experiencing increased interest since the availability of the miniature vapourizing device. However, the effectiveness of scavenging systems in the presence of humidifiers in the ventilator circuit is unknown.

Approach methods: We performed a bench study to evaluate the effectiveness of the Deltasorb® scavenging system in the presence of isoflurane and active humidity by simulating both infant and child ventilator test settings. A total of four ventilators were set to ventilate test lungs, all with active humidity and a Deltasorb scavenging canister collecting exhaled ventilation gas. Two ventilators also had isoflurane delivered using the Anesthesia Conserving Device- small (ACD®-S) on the inspiratory limb (also called alternative ventilator configuration). We performed instantaneous measurements of isoflurane and continuous sampling with passive badges to measure average environmental exposure over a test period of 6.5 hours. Scavenging canisters were returned to the company, where desorption analysis showed the volume of water and isoflurane captured in each canister.

Findings: Both instantaneous point sampling and diffusive sampling results were below the occupational exposure limit confirming safety. The canisters collected both isoflurane and a portion of the water vapour delivered; the percentage of captured water and isoflurane collected in infants was higher than the child ventilator test settings.

Practice implications conclusion: The tested scavenging configuration was effective in maintaining a safe working environment with active humidity and inspiratory limb (alternative) ventilator configuration of the the miniature vapourizing device.

简介:自微型汽化装置问世以来,在儿科重症监护室(PICU)中使用挥发性麻醉剂越来越受到关注。然而,在呼吸机回路中存在加湿器的情况下,清除系统的有效性尚不清楚:我们进行了一项工作台研究,通过模拟婴儿和儿童呼吸机测试设置,评估 Deltasorb® 净化系统在异氟醚和活性湿度存在时的有效性。共设置了四台呼吸机对测试肺部进行通气,所有呼吸机都带有活性湿度和收集呼出通气气体的 Deltasorb 清除罐。两台呼吸机还在吸气肢上使用小型麻醉保护装置 (ACD®-S) 输送异氟烷(也称为替代呼吸机配置)。我们对异氟醚进行了瞬时测量,并使用被动徽章进行了连续采样,以测量 6.5 小时试验期间的平均环境暴露量。清除罐被送回公司,解吸分析显示了每个清除罐中捕获的水和异氟醚的体积:瞬时点采样和扩散采样结果均低于职业接触限值,证明是安全的。滤毒罐既收集了异氟醚,也收集了部分输送的水蒸气;婴儿体内收集的水和异氟醚的百分比高于儿童呼吸机测试设置:结论:所测试的清除配置可有效保持安全的工作环境,同时还能保持湿度和吸气肢(替代)呼吸机配置的微型蒸发装置。
{"title":"Volatile gas scavenging in the paediatric intensive care unit: Occupational health and safety assessment.","authors":"Katherine Reise, Jason Macartney, Richard La, Angela Jerath, Marat Slessarev, Brian H Cuthbertson, Saptharishi Lalgudi Ganesan, Nicole K McKinnon","doi":"10.29390/001c.118513","DOIUrl":"10.29390/001c.118513","url":null,"abstract":"<p><strong>Introduction: </strong>The use of volatile anesthetic agents in the paediatric intensive care unit (PICU) is experiencing increased interest since the availability of the miniature vapourizing device. However, the effectiveness of scavenging systems in the presence of humidifiers in the ventilator circuit is unknown.</p><p><strong>Approach methods: </strong>We performed a bench study to evaluate the effectiveness of the Deltasorb® scavenging system in the presence of isoflurane and active humidity by simulating both infant and child ventilator test settings. A total of four ventilators were set to ventilate test lungs, all with active humidity and a Deltasorb scavenging canister collecting exhaled ventilation gas. Two ventilators also had isoflurane delivered using the Anesthesia Conserving Device- small (ACD®-S) on the inspiratory limb (also called alternative ventilator configuration). We performed instantaneous measurements of isoflurane and continuous sampling with passive badges to measure average environmental exposure over a test period of 6.5 hours. Scavenging canisters were returned to the company, where desorption analysis showed the volume of water and isoflurane captured in each canister.</p><p><strong>Findings: </strong>Both instantaneous point sampling and diffusive sampling results were below the occupational exposure limit confirming safety. The canisters collected both isoflurane and a portion of the water vapour delivered; the percentage of captured water and isoflurane collected in infants was higher than the child ventilator test settings.</p><p><strong>Practice implications conclusion: </strong>The tested scavenging configuration was effective in maintaining a safe working environment with active humidity and inspiratory limb (alternative) ventilator configuration of the the miniature vapourizing device.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"95-102"},"PeriodicalIF":0.0,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study. 评估长期吸入皮质类固醇治疗对 COVID-19 和并存慢性肺病患者的影响:一项多中心回顾性队列研究。
Q2 Health Professions Pub Date : 2024-06-05 eCollection Date: 2024-01-01 DOI: 10.29390/001c.118514
Adela Pina Belmonte, Manuel Madrazo, Laura Piles, Manuel Rubio-Rivas, Lucía de Jorge Huerta, María Gómez Antúnez, Juan Francisco López Caleya, Francisco Arnalich Fernández, Martin Gericó-Aseguinolaza, Paula Maria Pesqueira Fontan, Nicolás Rhyman, Marina Prieto Dehesa, Juan Luis Romero Cabrera, Gema María García García, Gonzalo García-Casasola, Ane Labirua-Iturburu Ruiz, Francisco Javier Carrasco-Sánchez, Sara Martínez Hernández, Maria de Los Reyes Pascual Pérez, José López Castro, José Luis Serrano Carrillo de Albornoz, José F Varona, Ricardo Gómez-Huelgas, Juan-Miguel Antón-Santos, Carlos Lumbreras-Bermejo

Background: Patients with chronic lung disease (CLD), such as asthma or chronic obstructive pulmonary disease, were expected to have an increased risk of clinical manifestations and severity of COVID-19. However, these comorbidities have been reported less frequently than expected. Chronic treatment with inhaled corticosteroids (ICS) may impact the clinical course of COVID-19. The main objective of this study is to know the influence of chronic treatment with ICS on the prognosis of COVID-19 hospitalized patients with CLD.

Methods: A multicenter retrospective cohort study was designed, including patients hospitalized with COVID-19. Epidemiological and clinical data were collected at admission and at seven days, and clinical outcomes were collected. Patients with CLD with and without chronic treatment with ICS were compared.

Results: Two thousand five hundred ninety-eight patients were included, of which 1,171 patients had a diagnosis of asthma and 1,427 of COPD (53.37% and 41.41% with ICS, respectively). No differences were found in mortality, transfer to ICU, or development of moderate-severe ARDS. Patients with chronic ICS had a longer hospital stay in both asthma and COPD patients (9 vs. 8 days, p = 0.031 in asthma patients), (11 vs. 9 days, p = 0.018 in COPD patients); although they also had more comorbidity burden.

Conclusions: Patients with chronic inhaled corticosteroids had longer hospital stays and more chronic comorbidities, measured by the Charlson comorbidity index, but they did not have more severe disease at admission, evaluated with qSOFA and PSI scores. Chronic treatment with inhaled corticosteroids had no influence on the prognosis of patients with chronic lung disease and COVID-19.

背景:患有慢性肺病(CLD)(如哮喘或慢性阻塞性肺病)的患者出现 COVID-19 临床表现和严重程度的风险预计会增加。然而,这些合并症的报道却比预期的要少。吸入性皮质类固醇(ICS)的长期治疗可能会影响 COVID-19 的临床过程。本研究的主要目的是了解长期使用 ICS 治疗对 COVID-19 CLD 住院患者预后的影响:方法:设计了一项多中心回顾性队列研究,包括 COVID-19 住院患者。研究收集了入院时和住院七天后的流行病学和临床数据,并收集了临床结果。对接受和未接受 ICS 慢性治疗的 CLD 患者进行了比较:结果:共纳入 2 598 名患者,其中 1 171 名患者被诊断为哮喘,1 427 名患者被诊断为慢性阻塞性肺疾病(分别有 53.37% 和 41.41% 的患者接受了 ICS 治疗)。在死亡率、转入重症监护室或发生中度-重度 ARDS 方面没有发现差异。在哮喘和慢性阻塞性肺病患者中,长期使用 ICS 的患者住院时间更长(哮喘患者为 9 天 vs. 8 天,p = 0.031),慢性阻塞性肺病患者为 11 天 vs. 9 天,p = 0.018);但他们的合并症负担也更重:结论:长期吸入皮质类固醇的患者住院时间更长,慢性合并症更多,以Charlson合并症指数衡量,但以qSOFA和PSI评分评估,他们入院时的病情并不更严重。吸入皮质类固醇的长期治疗对慢性肺病和COVID-19患者的预后没有影响。
{"title":"Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study.","authors":"Adela Pina Belmonte, Manuel Madrazo, Laura Piles, Manuel Rubio-Rivas, Lucía de Jorge Huerta, María Gómez Antúnez, Juan Francisco López Caleya, Francisco Arnalich Fernández, Martin Gericó-Aseguinolaza, Paula Maria Pesqueira Fontan, Nicolás Rhyman, Marina Prieto Dehesa, Juan Luis Romero Cabrera, Gema María García García, Gonzalo García-Casasola, Ane Labirua-Iturburu Ruiz, Francisco Javier Carrasco-Sánchez, Sara Martínez Hernández, Maria de Los Reyes Pascual Pérez, José López Castro, José Luis Serrano Carrillo de Albornoz, José F Varona, Ricardo Gómez-Huelgas, Juan-Miguel Antón-Santos, Carlos Lumbreras-Bermejo","doi":"10.29390/001c.118514","DOIUrl":"10.29390/001c.118514","url":null,"abstract":"<p><strong>Background: </strong>Patients with chronic lung disease (CLD), such as asthma or chronic obstructive pulmonary disease, were expected to have an increased risk of clinical manifestations and severity of COVID-19. However, these comorbidities have been reported less frequently than expected. Chronic treatment with inhaled corticosteroids (ICS) may impact the clinical course of COVID-19. The main objective of this study is to know the influence of chronic treatment with ICS on the prognosis of COVID-19 hospitalized patients with CLD.</p><p><strong>Methods: </strong>A multicenter retrospective cohort study was designed, including patients hospitalized with COVID-19. Epidemiological and clinical data were collected at admission and at seven days, and clinical outcomes were collected. Patients with CLD with and without chronic treatment with ICS were compared.</p><p><strong>Results: </strong>Two thousand five hundred ninety-eight patients were included, of which 1,171 patients had a diagnosis of asthma and 1,427 of COPD (53.37% and 41.41% with ICS, respectively). No differences were found in mortality, transfer to ICU, or development of moderate-severe ARDS. Patients with chronic ICS had a longer hospital stay in both asthma and COPD patients (9 vs. 8 days, <i>p =</i> 0.031 in asthma patients), (11 vs. 9 days, <i>p =</i> 0.018 in COPD patients); although they also had more comorbidity burden.</p><p><strong>Conclusions: </strong>Patients with chronic inhaled corticosteroids had longer hospital stays and more chronic comorbidities, measured by the Charlson comorbidity index, but they did not have more severe disease at admission, evaluated with qSOFA and PSI scores. Chronic treatment with inhaled corticosteroids had no influence on the prognosis of patients with chronic lung disease and COVID-19.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"86-94"},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141296936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of adding a six-month Pilates exercise program to three months of traditional community-based pulmonary rehabilitation in individuals with COPD: a prospective cohort study. 在慢性阻塞性肺病患者三个月传统社区肺康复基础上增加六个月普拉提锻炼计划的效果:一项前瞻性队列研究。
Q2 Health Professions Pub Date : 2024-05-30 eCollection Date: 2024-01-01 DOI: 10.29390/001c.117966
Marisela Barbosa, Cristina A de Melo, Rui Torres

Introduction: Pilates exercise may complement traditional pulmonary rehabilitation in individuals with chronic obstructive pulmonary disease (COPD). The objective was to analyze the effects of adding a six-month Pilates exercise program to a three-month pulmonary rehabilitation for individuals with COPD.

Methods: Thirty-five participants with COPD (GOLD B) were assigned to the intervention (n=14) or control (n=21) group. Both groups received an initial three months of a pulmonary rehabilitation program. The intervention group further underwent six months of pilates. Participants were evaluated at baseline and at three, six, and nine months. Lung function and strength of respiratory muscles were defined as primary outcomes. Secondary outcomes included cardiac, physical function, and exacerbation episodes.

Results: There were no consistent statistically significant differences between groups for the lung function outcomes (p<0.05). Maximal inspiratory and expiratory pressure increased significantly at three months in both groups (p<0.05). It was significantly superior in the intervention group at nine months for maximal inspiratory pressure (p=0.005) and six and nine months for maximal expiratory pressure (p=0.027 and p<0.001, respectively). Changes in muscle strength (knee extension and handgrip) were comparable between groups (p>0.05), but exercise-induced fatigue and balance were significantly superior in the intervention group at the six- and nine-month follow-ups (p<0.05).

Discussion: Pilates exercise programs may be implemented to augment traditional pulmonary rehabilitation with the goal of improving the strength of respiratory muscles.

Conclusion: Adding a Pilates exercise program to pulmonary rehabilitation resulted in superior strength of respiratory muscles, higher resistance to exercise-induced fatigue, and improved balance.

简介:普拉提运动可作为慢性阻塞性肺病(COPD)患者传统肺康复治疗的补充。该研究旨在分析在为慢性阻塞性肺病患者提供的三个月肺康复治疗的基础上增加六个月普拉提锻炼计划的效果:35 名慢性阻塞性肺病患者(GOLD B)被分配到干预组(14 人)或对照组(21 人)。两组患者均接受了为期三个月的肺康复计划。干预组进一步接受六个月的普拉提训练。分别在基线期、三个月、六个月和九个月时对参与者进行评估。肺功能和呼吸肌力量被定义为主要结果。次要结果包括心脏功能、身体功能和病情恶化情况:结果:在肺功能结果(ppp=0.005)和六个月及九个月最大呼气压力(p=0.027 和 pp>0.05)方面,组间差异无统计学意义,但在六个月和九个月的随访中,干预组在运动引起的疲劳和平衡方面明显优于干预组(pdiscussion:普拉提运动项目可用于增强传统的肺康复训练,以提高呼吸肌的力量:结论:在肺康复治疗中加入普拉提运动项目能增强呼吸肌的力量,提高对运动引起的疲劳的抵抗力,并改善平衡能力。
{"title":"The effects of adding a six-month Pilates exercise program to three months of traditional community-based pulmonary rehabilitation in individuals with COPD: a prospective cohort study.","authors":"Marisela Barbosa, Cristina A de Melo, Rui Torres","doi":"10.29390/001c.117966","DOIUrl":"10.29390/001c.117966","url":null,"abstract":"<p><strong>Introduction: </strong>Pilates exercise may complement traditional pulmonary rehabilitation in individuals with chronic obstructive pulmonary disease (COPD). The objective was to analyze the effects of adding a six-month Pilates exercise program to a three-month pulmonary rehabilitation for individuals with COPD.</p><p><strong>Methods: </strong>Thirty-five participants with COPD (GOLD B) were assigned to the intervention (n=14) or control (n=21) group. Both groups received an initial three months of a pulmonary rehabilitation program. The intervention group further underwent six months of pilates. Participants were evaluated at baseline and at three, six, and nine months. Lung function and strength of respiratory muscles were defined as primary outcomes. Secondary outcomes included cardiac, physical function, and exacerbation episodes.</p><p><strong>Results: </strong>There were no consistent statistically significant differences between groups for the lung function outcomes (<i>p</i><0.05). Maximal inspiratory and expiratory pressure increased significantly at three months in both groups (<i>p</i><0.05). It was significantly superior in the intervention group at nine months for maximal inspiratory pressure (<i>p</i>=0.005) and six and nine months for maximal expiratory pressure (<i>p</i>=0.027 and <i>p</i><0.001, respectively). Changes in muscle strength (knee extension and handgrip) were comparable between groups (<i>p</i>>0.05), but exercise-induced fatigue and balance were significantly superior in the intervention group at the six- and nine-month follow-ups (<i>p</i><0.05).</p><p><strong>Discussion: </strong>Pilates exercise programs may be implemented to augment traditional pulmonary rehabilitation with the goal of improving the strength of respiratory muscles.</p><p><strong>Conclusion: </strong>Adding a Pilates exercise program to pulmonary rehabilitation resulted in superior strength of respiratory muscles, higher resistance to exercise-induced fatigue, and improved balance.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"68-85"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11144029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141198999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proceedings from the Canadian Society of Respiratory Therapists Annual Conference May 3-5, 2024 加拿大呼吸治疗师协会年会论文集,2024 年 5 月 3-5 日
Q2 Health Professions Pub Date : 2024-05-13 DOI: 10.29390/001c.117111
Conference abstracts
会议摘要
{"title":"Proceedings from the Canadian Society of Respiratory Therapists Annual Conference May 3-5, 2024","authors":"","doi":"10.29390/001c.117111","DOIUrl":"https://doi.org/10.29390/001c.117111","url":null,"abstract":"Conference abstracts","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140982191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-care lung ultrasound in detecting pneumonia: A systematic review. 用于检测肺炎的护理点肺部超声波:系统综述。
Q2 Health Professions Pub Date : 2024-01-29 eCollection Date: 2024-01-01 DOI: 10.29390/001c.92182
Iqra Abid, Nadia Qureshi, Nicola Lategan, Simon Williams, Sidra Shahid

Purpose: Limited evidence exists to assess the sensitivity, specificity, and accuracy of point-of-care lung ultrasound (LUS) across all age groups. This review aimed to investigate the benefits of point-of-care LUS for the early diagnosis of pneumonia compared to traditional chest X-rays (CXR) in a subgroup analysis including pediatric, adult, and geriatric populations.

Material and methods: This systematic review examined systematic reviews, meta-analyses, and original research from 2017 to 2021, comparing point-of-care LUS and CXR in diagnosing pneumonia among adults, pediatrics and geriatrics. Studies lacking direct comparison or exploring diseases other than pneumonia, case reports, and those examining pneumonia secondary to COVID-19 variants were excluded. The search utilized PubMed, Google Scholar, and Cochrane databases with specific search strings. The study selection, conducted by two independent investigators, demonstrated an agreement by the Kappa index, ensuring reliable article selection. The QUADAS-2 tool assessed the selected studies for quality, highlighting risk of bias and applicability concerns across key domains. Statistical analysis using Stata Version 16 determined pooled sensitivity and specificity via a bivariate model, emphasizing LUS and CXR diagnostic capabilities. Additionally, RevMan 5.4.1 facilitated the calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), offering insights into diagnostic accuracy.

Results: The search, conducted across PubMed, Google Scholar, and Cochrane Library databases by two independent investigators, initially identified 1045 articles. Following screening processes, 12 studies comprised a sample size of 2897. LUS demonstrated a likelihood ratio of 5.09, a specificity of 81.91%, and a sensitivity of 92.13% in detecting pneumonia in pediatric, adult, and geriatric patients, with a p-value of 0.0002 and a 95% confidence interval, indicating diagnostic accuracy ranging from 84.07% to 96.29% when compared directly to CXR.

Conclusion: Our review supports that LUS can play a valuable role in detecting pneumonia early with high sensitivity, specificity, and diagnostic accuracy across diverse patient demographics, including pediatric, adult, and geriatric populations. Since it overcomes most of the limitations of CXR and other diagnostic modalities, it can be utilized as a diagnostic tool for pneumonia for all age groups as it is a safe, readily available, and cost-effective modality that can be utilized in an emergency department, intensive care units, wards, and clinics by trained respiratory care professionals.

目的:评估各年龄段护理点肺部超声检查(LUS)灵敏度、特异性和准确性的证据有限。本综述旨在通过包括儿科、成人和老年群体在内的亚组分析,研究与传统胸部 X 光检查(CXR)相比,护理点肺部超声检查对肺炎早期诊断的益处:本系统综述研究了2017年至2021年的系统综述、荟萃分析和原创研究,比较了床旁LUS和CXR在诊断成人、儿科和老年肺炎方面的效果。缺乏直接比较或探讨肺炎以外疾病的研究、病例报告以及研究 COVID-19 变异继发肺炎的研究均被排除在外。检索使用了 PubMed、Google Scholar 和 Cochrane 数据库的特定检索字符串。研究选择由两名独立研究人员进行,Kappa指数显示双方意见一致,确保了文章选择的可靠性。QUADAS-2 工具对所选研究进行了质量评估,强调了偏倚风险和关键领域的适用性问题。使用 Stata Version 16 进行统计分析,通过双变量模型确定汇总的敏感性和特异性,强调 LUS 和 CXR 的诊断能力。此外,RevMan 5.4.1 还有助于计算灵敏度、特异性、阳性预测值 (PPV) 和阴性预测值 (NPV),从而深入了解诊断的准确性:由两名独立调查人员在 PubMed、谷歌学术和 Cochrane 图书馆数据库中进行的搜索,最初发现了 1045 篇文章。经过筛选,12 项研究的样本量为 2897 个。LUS在检测小儿、成人和老年患者肺炎方面的似然比为5.09,特异性为81.91%,灵敏度为92.13%,P值为0.0002,置信区间为95%,与CXR直接比较,诊断准确率为84.07%至96.29%:我们的综述证明,LUS 可在早期发现肺炎方面发挥重要作用,其灵敏度、特异性和诊断准确性较高,适用于不同的患者人群,包括儿科、成人和老年人群。由于 LUS 克服了 CXR 和其他诊断方法的大部分局限性,因此可作为所有年龄组的肺炎诊断工具,因为它是一种安全、随时可用且经济有效的方法,可由经过培训的呼吸护理专业人员在急诊科、重症监护室、病房和诊所使用。
{"title":"Point-of-care lung ultrasound in detecting pneumonia: A systematic review.","authors":"Iqra Abid, Nadia Qureshi, Nicola Lategan, Simon Williams, Sidra Shahid","doi":"10.29390/001c.92182","DOIUrl":"10.29390/001c.92182","url":null,"abstract":"<p><strong>Purpose: </strong>Limited evidence exists to assess the sensitivity, specificity, and accuracy of point-of-care lung ultrasound (LUS) across all age groups. This review aimed to investigate the benefits of point-of-care LUS for the early diagnosis of pneumonia compared to traditional chest X-rays (CXR) in a subgroup analysis including pediatric, adult, and geriatric populations.</p><p><strong>Material and methods: </strong>This systematic review examined systematic reviews, meta-analyses, and original research from 2017 to 2021, comparing point-of-care LUS and CXR in diagnosing pneumonia among adults, pediatrics and geriatrics. Studies lacking direct comparison or exploring diseases other than pneumonia, case reports, and those examining pneumonia secondary to COVID-19 variants were excluded. The search utilized PubMed, Google Scholar, and Cochrane databases with specific search strings. The study selection, conducted by two independent investigators, demonstrated an agreement by the Kappa index, ensuring reliable article selection. The QUADAS-2 tool assessed the selected studies for quality, highlighting risk of bias and applicability concerns across key domains. Statistical analysis using Stata Version 16 determined pooled sensitivity and specificity via a bivariate model, emphasizing LUS and CXR diagnostic capabilities. Additionally, RevMan 5.4.1 facilitated the calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), offering insights into diagnostic accuracy.</p><p><strong>Results: </strong>The search, conducted across PubMed, Google Scholar, and Cochrane Library databases by two independent investigators, initially identified 1045 articles. Following screening processes, 12 studies comprised a sample size of 2897. LUS demonstrated a likelihood ratio of 5.09, a specificity of 81.91%, and a sensitivity of 92.13% in detecting pneumonia in pediatric, adult, and geriatric patients, with a p-value of 0.0002 and a 95% confidence interval, indicating diagnostic accuracy ranging from 84.07% to 96.29% when compared directly to CXR.</p><p><strong>Conclusion: </strong>Our review supports that LUS can play a valuable role in detecting pneumonia early with high sensitivity, specificity, and diagnostic accuracy across diverse patient demographics, including pediatric, adult, and geriatric populations. Since it overcomes most of the limitations of CXR and other diagnostic modalities, it can be utilized as a diagnostic tool for pneumonia for all age groups as it is a safe, readily available, and cost-effective modality that can be utilized in an emergency department, intensive care units, wards, and clinics by trained respiratory care professionals.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"37-48"},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10830142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139651870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Making respiratory care safe for neonatal and paediatric intensive care unit staff: mitigation strategies and use of filters. 为新生儿和儿科重症监护室工作人员提供安全的呼吸护理:缓解策略和过滤器的使用。
Q2 Health Professions Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.29390/001c.91262
Bradley G Carter, Edward Harcourt, Alexandra Harris, Michael Zampetti, Trevor Duke, David Tingay

Background: Many medical devices in pediatric and newborn intensive care units can potentially expose healthcare workers (HCWs) and others to transmission of respiratory and other viruses and bacteria. Such fomites include ventilators, nebulizers, and monitoring equipment.

Approach: We report the general, novel approach we have taken to identify and mitigate these risks and to protect HCWs, visitors and patients from exposure while maintaining the optimal performance of such respiratory equipment.

Findings: The approach combined a high level of personal protective equipment (PPE), strict hand hygiene, air filtration and air conditioning and other relevant viral risk mitigation guidelines. This report describes the experiences from the SARS-CoV-2 pandemic to provide a reference framework that can be applied generally. The steps we took consisted of auditing our equipment and processes to identify risk through sources of potentially contaminated gas that may contain aerosolized virus, seeking advice and liaising with suppliers/manufacturers, devising mitigation strategies using indirect and direct approaches (largely filtering), performing tests on equipment to verify proper function and the absence of negative impacts and the development and implementation of relevant procedures and practices. We had a multidisciplinary team to guide the process. We monitored daily for hospital-acquired infections among staff caring for SARS-CoV-2 patients.

Conclusion: Our approach was successful as we have continued to offer optimal intensive care to our patients, and we did not find any healthcare worker who was infected through the course of caring for patients at the bedside. The lessons learnt will be of benefit to future local outbreaks or pandemics.

背景:儿科和新生儿重症监护室中的许多医疗设备都有可能使医护人员(HCWs)及其他人员受到呼吸道及其他病毒和细菌的传播。这些传播媒介包括呼吸机、雾化器和监护设备:我们报告了我们为识别和降低这些风险以及保护医护人员、来访者和患者免于接触并保持此类呼吸设备的最佳性能而采取的一般新方法:该方法结合了高水平的个人防护设备 (PPE)、严格的手部卫生、空气过滤和空调以及其他相关的病毒风险缓解指南。本报告介绍了 SARS-CoV-2 大流行的经验,提供了一个可普遍应用的参考框架。我们采取的措施包括:对设备和流程进行审核,以确定可能含有气溶胶病毒的潜在污染气体来源所带来的风险;寻求建议并与供应商/制造商联系;利用间接和直接方法(主要是过滤)制定缓解策略;对设备进行测试以验证其功能是否正常,以及是否存在负面影响;制定并实施相关程序和做法。我们有一个多学科团队来指导这一过程。我们每天都对护理 SARS-CoV-2 病人的工作人员的院内感染情况进行监测:我们的方法是成功的,因为我们继续为病人提供最佳的重症监护,而且我们没有发现任何医护人员在床边护理病人的过程中受到感染。我们吸取的经验教训将有助于应对未来的本地疫情爆发或大流行。
{"title":"Making respiratory care safe for neonatal and paediatric intensive care unit staff: mitigation strategies and use of filters.","authors":"Bradley G Carter, Edward Harcourt, Alexandra Harris, Michael Zampetti, Trevor Duke, David Tingay","doi":"10.29390/001c.91262","DOIUrl":"10.29390/001c.91262","url":null,"abstract":"<p><strong>Background: </strong>Many medical devices in pediatric and newborn intensive care units can potentially expose healthcare workers (HCWs) and others to transmission of respiratory and other viruses and bacteria. Such fomites include ventilators, nebulizers, and monitoring equipment.</p><p><strong>Approach: </strong>We report the general, novel approach we have taken to identify and mitigate these risks and to protect HCWs, visitors and patients from exposure while maintaining the optimal performance of such respiratory equipment.</p><p><strong>Findings: </strong>The approach combined a high level of personal protective equipment (PPE), strict hand hygiene, air filtration and air conditioning and other relevant viral risk mitigation guidelines. This report describes the experiences from the SARS-CoV-2 pandemic to provide a reference framework that can be applied generally. The steps we took consisted of auditing our equipment and processes to identify risk through sources of potentially contaminated gas that may contain aerosolized virus, seeking advice and liaising with suppliers/manufacturers, devising mitigation strategies using indirect and direct approaches (largely filtering), performing tests on equipment to verify proper function and the absence of negative impacts and the development and implementation of relevant procedures and practices. We had a multidisciplinary team to guide the process. We monitored daily for hospital-acquired infections among staff caring for SARS-CoV-2 patients.</p><p><strong>Conclusion: </strong>Our approach was successful as we have continued to offer optimal intensive care to our patients, and we did not find any healthcare worker who was infected through the course of caring for patients at the bedside. The lessons learnt will be of benefit to future local outbreaks or pandemics.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"13-27"},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10881236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive airway pressure therapy adherence and outcomes in obstructive sleep apnea: An exploratory longitudinal retrospective randomized chart review 阻塞性睡眠呼吸暂停患者的气道正压疗法坚持率和疗效:探索性纵向回顾随机病历审查
Q2 Health Professions Pub Date : 2024-01-12 DOI: 10.29390/001c.92080
Daniel Stevens, Michaela Title, Kathleen Spurr, Debra Morrison
Positive airway pressure (PAP) therapy is prescribed to patients with obstructive sleep apnea (OSA). A commonly used definition for PAP therapy adherence is based upon the minimum requirements to receive Medicare coverage in the US, defined as PAP usage of four or more hours per night on 70 percent of nights for at least 30 consecutive days. However, little evidence exists to support this definition for PAP therapy adherence. Therefore, the present study sought to determine the efficacy of the present definition of PAP therapy adherence on longitudinal outcomes in patients with OSA, using objectively measured PAP device usage time. An exploratory longitudinal, retrospective, randomized chart review was done to assess clinical outcomes between patients with OSA who were defined as PAP therapy adherent (n=50) and non-adherent (n=50) during an eight-year observation period. No significant differences were shown between groups for mortality, hospitalizations, or development of co-morbidities during the observation period. However, logistic regression showed significantly higher odds of adherence in male patients compared to female patients (OR=8.519; 95%CI=1.301–55.756; p=0.025) and significantly lower odds of adherence in patients with higher normal (OR=0.039; 95%CI=0.005–0.392; p=0.003), mild excessive (OR=0.039; 95%CI=0.003–0.517; p=0.014), and severe excessive (OR=0.088; 95%CI=0.012–0.635; p=0.016) daytime sleepiness compared to patients with lower normal daytime sleepiness. An increasing number of hospitalizations also corresponded with a significant decrease in odds of being adherent (OR=0.741; 95%CI=0.551–0.995; p=0.046). The present study supports a steadily growing body of literature calling for more consideration and evidence to support a definition of PAP therapy adherence that is clinically meaningful.
阻塞性睡眠呼吸暂停(OSA)患者需要接受气道正压(PAP)治疗。通常使用的正压通气疗法坚持治疗的定义是基于美国医疗保险的最低要求,即至少连续 30 天有 70% 的夜晚每晚使用正压通气疗法 4 小时或以上。然而,几乎没有证据支持这一关于 PAP 治疗依从性的定义。因此,本研究试图利用客观测量的 PAP 设备使用时间来确定目前的 PAP 治疗依从性定义对 OSA 患者纵向疗效的影响。本研究采用探索性纵向、回顾性、随机病历审查的方法,评估了在八年观察期内被定义为坚持使用气囊导引器治疗(50 人)和不坚持使用气囊导引器治疗(50 人)的 OSA 患者的临床疗效。在观察期内,两组患者的死亡率、住院率或并发症发生率无明显差异。然而,逻辑回归结果显示,男性患者坚持治疗的几率明显高于女性患者(OR=8.519;95%CI=1.301-55.756;P=0.025),而正常值较高的患者坚持治疗的几率明显低于男性患者(OR=0.039;95%CI=0.005-0.392;p=0.003)、轻度过度(OR=0.039;95%CI=0.003-0.517;p=0.014)和重度过度(OR=0.088;95%CI=0.012-0.635;p=0.016)白天嗜睡与白天嗜睡正常程度较低的患者相比,坚持治疗的几率明显较低。住院次数的增加也与坚持治疗几率的显著下降相对应(OR=0.741;95%CI=0.551-0.995;p=0.046)。目前有越来越多的文献呼吁对具有临床意义的 PAP 治疗依从性定义进行更多的考虑和证据支持,本研究为这些文献提供了支持。
{"title":"Positive airway pressure therapy adherence and outcomes in obstructive sleep apnea: An exploratory longitudinal retrospective randomized chart review","authors":"Daniel Stevens, Michaela Title, Kathleen Spurr, Debra Morrison","doi":"10.29390/001c.92080","DOIUrl":"https://doi.org/10.29390/001c.92080","url":null,"abstract":"Positive airway pressure (PAP) therapy is prescribed to patients with obstructive sleep apnea (OSA). A commonly used definition for PAP therapy adherence is based upon the minimum requirements to receive Medicare coverage in the US, defined as PAP usage of four or more hours per night on 70 percent of nights for at least 30 consecutive days. However, little evidence exists to support this definition for PAP therapy adherence. Therefore, the present study sought to determine the efficacy of the present definition of PAP therapy adherence on longitudinal outcomes in patients with OSA, using objectively measured PAP device usage time. An exploratory longitudinal, retrospective, randomized chart review was done to assess clinical outcomes between patients with OSA who were defined as PAP therapy adherent (n=50) and non-adherent (n=50) during an eight-year observation period. No significant differences were shown between groups for mortality, hospitalizations, or development of co-morbidities during the observation period. However, logistic regression showed significantly higher odds of adherence in male patients compared to female patients (OR=8.519; 95%CI=1.301–55.756; p=0.025) and significantly lower odds of adherence in patients with higher normal (OR=0.039; 95%CI=0.005–0.392; p=0.003), mild excessive (OR=0.039; 95%CI=0.003–0.517; p=0.014), and severe excessive (OR=0.088; 95%CI=0.012–0.635; p=0.016) daytime sleepiness compared to patients with lower normal daytime sleepiness. An increasing number of hospitalizations also corresponded with a significant decrease in odds of being adherent (OR=0.741; 95%CI=0.551–0.995; p=0.046). The present study supports a steadily growing body of literature calling for more consideration and evidence to support a definition of PAP therapy adherence that is clinically meaningful.","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":" 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139624904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring knowledge gaps and research needs in respiratory therapy: a qualitative description study. 探索呼吸疗法的知识差距和研究需求:定性描述研究。
Q2 Health Professions Pub Date : 2024-01-03 eCollection Date: 2024-01-01 DOI: 10.29390/001c.91184
Marco Zaccagnini, Andrew West, Esther Khor, Shirley Quach, Mika L Nonoyama

Background: Respiratory therapists (RTs) are expected to stay updated on technology, treatments, research, and best practices to provide high-quality patient care. They must possess the skills to interpret, evaluate, and contribute to evidence-based practices. However, RTs often rely on research from other professions that may not fully address their specific needs, leading to insufficient guidance for their practice. Additionally, there has been no exploration of knowledge gaps and research needs from RTs' perspectives to enhance their practice and patient outcomes. The research questions guiding this study were: (i) what are the perceived practice-oriented knowledge gaps? and (ii) what are the necessary research priorities across the respiratory therapy profession according to experts in respiratory therapy?

Methods: A qualitative description study was conducted using semi-structured focus groups with 40 expert RTs from seven areas of practice across Canada. Data was analyzed using qualitative content analysis.

Results: We identified four major themes relating to what these experts perceive as the practice-oriented gaps and necessary research priorities across the respiratory therapy profession: 1) system-level impact of RTs, 2) optimizing respiratory therapy practices, 3) scholarship on the respiratory therapy profession and 4) respiratory therapy education.

Discussion: The findings establish a fundamental understanding of the current gaps and the specific needs of RTs that require further investigation. Participants strongly emphasized the significance of research priorities that consider the breadth and depth of the respiratory therapy profession, which underscores the complex nature of respiratory therapy and its application in practice.

Conclusion: The unique insights garnered from this study highlight the knowledge gaps and research needs specific to RTs. These findings pave the way for further exploration, discourse, and research aimed at understanding the specific contributions and requirements of RTs.

背景:人们期望呼吸治疗师(RTs)不断更新技术、治疗、研究和最佳实践,以提供高质量的患者护理。他们必须具备解释、评估和促进循证实践的技能。然而,康复治疗师往往依赖于其他专业的研究,而这些研究可能无法完全满足他们的特定需求,从而导致对他们的实践指导不足。此外,还没有从 RTs 的角度探讨知识差距和研究需求,以提高他们的实践水平和患者的治疗效果。指导本研究的研究问题是(i) 以实践为导向的知识差距是什么? (ii) 根据呼吸治疗专家的观点,整个呼吸治疗专业的必要研究重点是什么?采用半结构化焦点小组的形式,对来自加拿大七个实践领域的 40 位 RT 专家进行了定性描述研究。采用定性内容分析法对数据进行分析:结果:我们确定了与这些专家所认为的整个呼吸治疗专业以实践为导向的差距和必要的研究重点相关的四大主题:1)呼吸治疗师的系统级影响;2)优化呼吸治疗实践;3)呼吸治疗专业的学术研究;4)呼吸治疗教育:讨论:研究结果使人们从根本上了解了目前存在的差距以及需要进一步调查的呼吸治疗师的具体需求。与会者大力强调了考虑呼吸治疗专业广度和深度的研究重点的重要性,这突出了呼吸治疗的复杂性及其在实践中的应用:本研究获得的独特见解凸显了呼吸治疗师特有的知识差距和研究需求。这些发现为进一步探索、讨论和研究了解呼吸治疗师的特殊贡献和要求铺平了道路。
{"title":"Exploring knowledge gaps and research needs in respiratory therapy: a qualitative description study.","authors":"Marco Zaccagnini, Andrew West, Esther Khor, Shirley Quach, Mika L Nonoyama","doi":"10.29390/001c.91184","DOIUrl":"10.29390/001c.91184","url":null,"abstract":"<p><strong>Background: </strong>Respiratory therapists (RTs) are expected to stay updated on technology, treatments, research, and best practices to provide high-quality patient care. They must possess the skills to interpret, evaluate, and contribute to evidence-based practices. However, RTs often rely on research from other professions that may not fully address their specific needs, leading to insufficient guidance for their practice. Additionally, there has been no exploration of knowledge gaps and research needs from RTs' perspectives to enhance their practice and patient outcomes. The research questions guiding this study were: (<i>i</i>) what are the perceived practice-oriented knowledge gaps? and (<i>ii</i>) what are the necessary research priorities across the respiratory therapy profession according to experts in respiratory therapy?</p><p><strong>Methods: </strong>A qualitative description study was conducted using semi-structured focus groups with 40 expert RTs from seven areas of practice across Canada. Data was analyzed using qualitative content analysis.</p><p><strong>Results: </strong>We identified four major themes relating to what these experts perceive as the practice-oriented gaps and necessary research priorities across the respiratory therapy profession: 1) system-level impact of RTs, 2) optimizing respiratory therapy practices, 3) scholarship on the respiratory therapy profession and 4) respiratory therapy education.</p><p><strong>Discussion: </strong>The findings establish a fundamental understanding of the current gaps and the specific needs of RTs that require further investigation. Participants strongly emphasized the significance of research priorities that consider the breadth and depth of the respiratory therapy profession, which underscores the complex nature of respiratory therapy and its application in practice.</p><p><strong>Conclusion: </strong>The unique insights garnered from this study highlight the knowledge gaps and research needs specific to RTs. These findings pave the way for further exploration, discourse, and research aimed at understanding the specific contributions and requirements of RTs.</p>","PeriodicalId":39373,"journal":{"name":"Canadian Journal of Respiratory Therapy","volume":"60 ","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2024-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10769513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian Journal of Respiratory Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1